MedPath

Enalapril Maleate

Enalapril Maleate Tablets, USP

Approved
Approval ID

f3754f29-9b75-4e2c-9c28-b3479f5bf906

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 2, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Enalapril Maleate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-6712
Application NumberANDA075657
Product Classification
M
Marketing Category
C73584
G
Generic Name
Enalapril Maleate
Product Specifications
Route of AdministrationORAL
Effective DateJuly 27, 2023
FDA Product Classification

INGREDIENTS (5)

ENALAPRIL MALEATEActive
Quantity: 10 mg in 1 1
Code: 9O25354EPJ
Classification: ACTIB
Sodium BicarbonateInactive
Code: 8MDF5V39QO
Classification: IACT
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
Starch, CornInactive
Code: O8232NY3SJ
Classification: IACT
Lactose MonohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Enalapril Maleate - FDA Drug Approval Details